AR064077A1 - Composiciones bajo forma de unguento sin vaselina que comprende un derivado de vitamina d y eventualmente un anti-inflamatorio esteroide - Google Patents
Composiciones bajo forma de unguento sin vaselina que comprende un derivado de vitamina d y eventualmente un anti-inflamatorio esteroideInfo
- Publication number
- AR064077A1 AR064077A1 ARP070105356A ARP070105356A AR064077A1 AR 064077 A1 AR064077 A1 AR 064077A1 AR P070105356 A ARP070105356 A AR P070105356A AR P070105356 A ARP070105356 A AR P070105356A AR 064077 A1 AR064077 A1 AR 064077A1
- Authority
- AR
- Argentina
- Prior art keywords
- vitamin
- eventually
- derivative
- vaseline
- inflammatory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Composicion en forma de ungüento, sin vaselina, principalmente para una aplicacion topica, que comprende un derivado de vitamina D y, eventualmente, un agente activo de la familia de los antiinflamatorios esteroides. Uso. Procedimiento.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0655205A FR2909284B1 (fr) | 2006-11-30 | 2006-11-30 | Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien |
Publications (1)
Publication Number | Publication Date |
---|---|
AR064077A1 true AR064077A1 (es) | 2009-03-11 |
Family
ID=38441906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070105356A AR064077A1 (es) | 2006-11-30 | 2007-11-30 | Composiciones bajo forma de unguento sin vaselina que comprende un derivado de vitamina d y eventualmente un anti-inflamatorio esteroide |
Country Status (13)
Country | Link |
---|---|
US (4) | US8741878B2 (es) |
EP (1) | EP2101726A2 (es) |
JP (1) | JP2011504870A (es) |
KR (1) | KR20090084898A (es) |
CN (1) | CN101541304B (es) |
AR (1) | AR064077A1 (es) |
AU (1) | AU2007327368B2 (es) |
BR (1) | BRPI0717695A2 (es) |
CA (1) | CA2670601A1 (es) |
FR (1) | FR2909284B1 (es) |
MX (1) | MX2009005307A (es) |
RU (1) | RU2448713C2 (es) |
WO (1) | WO2008065316A2 (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2931662B1 (fr) * | 2008-05-30 | 2010-07-30 | Galderma Res & Dev | Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise. |
FR2931663B1 (fr) * | 2008-05-30 | 2010-07-30 | Galderma Res & Dev | Nouvelles compositions depigmentantes anhydre comprenant un derive phenolique solubilise. |
EP2419082B1 (fr) * | 2008-12-23 | 2020-01-22 | Galderma S.A. | Composition pharmaceutique topique comprenant un principe actif sensible a l'eau |
EP2509632B1 (en) | 2009-12-10 | 2023-05-03 | Guerry L. Grune | Glycerine based jelly compositions |
EP2515865B1 (en) * | 2009-12-22 | 2016-12-14 | Leo Pharma A/S | Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants |
AU2010335656B2 (en) * | 2009-12-22 | 2015-05-07 | Leo Pharma A/S | Pharmaceutical composition comprising solvent mixture and a vitamin D derivative or analogue |
EP2515912A4 (en) * | 2009-12-22 | 2013-12-25 | Leo Pharma As | PHARMACEUTICAL COMPOSITION WITH VITAMIN D ANALOGON AND COLOSTERS-TENSID MIXTURE |
US9254296B2 (en) | 2009-12-22 | 2016-02-09 | Leo Pharma A/S | Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture |
JP2014508796A (ja) * | 2011-03-24 | 2014-04-10 | レオ ファーマ アクティーゼルスカブ | 脂質ナノ粒子とコルチコステロイドまたはビタミンd誘導体とを含む組成物 |
RU2496476C1 (ru) * | 2012-08-10 | 2013-10-27 | Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "УрНИИДВиИ" Минздравсоцразвития России) | Средство наружной терапии для больных атопическим дерматитом |
CN103142495B (zh) * | 2013-03-21 | 2014-08-20 | 青岛正大海尔制药有限公司 | 骨化三醇混悬颗粒及其制备方法 |
CN103142486B (zh) * | 2013-03-21 | 2014-08-20 | 青岛正大海尔制药有限公司 | 骨化三醇散剂及其制备方法 |
CN103142467B (zh) * | 2013-03-21 | 2014-07-02 | 青岛正大海尔制药有限公司 | 骨化三醇软膏及其制备方法 |
RU2698796C2 (ru) * | 2013-10-11 | 2019-08-30 | Бетта Фармасьютикалз Ко., Лтд | Икотиниб-содержащие местнодействующие накожные фармацевтические композиции и их применения |
US9913787B2 (en) | 2015-05-18 | 2018-03-13 | Guerry L. Grune | Glycerine based jelly compositions |
CN107157918B (zh) * | 2016-03-08 | 2019-12-27 | 上海通用药业股份有限公司 | 一种用于银屑病治疗的半固体制剂的制备方法 |
CN107157919B (zh) * | 2016-03-08 | 2019-12-27 | 上海通用药业股份有限公司 | 一种用于治疗银屑病的半固体制剂的制备方法 |
CN107157920B (zh) * | 2016-03-08 | 2019-12-27 | 上海通用药业股份有限公司 | 一种包含维生素d或其衍生物的半固体制剂的制备方法 |
CN107157917B (zh) * | 2016-03-08 | 2019-12-27 | 上海通用药业股份有限公司 | 一种用于治疗银屑病的软膏的制备方法 |
CN108969527B (zh) * | 2017-05-31 | 2021-05-11 | 上海通用药业股份有限公司 | 一种药物制剂及其制备方法和用途 |
CN109453180A (zh) * | 2018-11-15 | 2019-03-12 | 广州南峰生物科技有限公司 | 生物活性维生素d衍生物或类似物的新用途 |
CN109568279B (zh) * | 2018-12-28 | 2020-10-20 | 正大制药(青岛)有限公司 | 一种氟骨化醇片剂及其制备方法 |
JP2023513694A (ja) * | 2020-02-11 | 2023-04-03 | タロー・ファーマシューティカル・インダストリーズ・リミテッド | デスオキシメタゾンおよびタザロテンを含む組成物 |
CN111743906A (zh) * | 2020-04-01 | 2020-10-09 | 南通华山药业有限公司 | 一种阿法骨化醇在制备干预皮肤光损伤外用制剂中的应用 |
CN114159567B (zh) * | 2020-09-10 | 2023-03-31 | 南京海融医药科技股份有限公司 | 一种治疗皮肤病的混悬凝胶剂 |
CN116531315B (zh) * | 2023-03-22 | 2024-02-13 | 江苏知原药业股份有限公司 | 一种卡泊三醇软膏及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6399014A (ja) * | 1986-10-15 | 1988-04-30 | Teijin Ltd | 乾癬治療用油脂性軟膏剤 |
FR2719220A1 (fr) * | 1994-04-29 | 1995-11-03 | Lafon Labor | Nouvelle forme galénique pour l'administration transdermique. |
JP4387465B2 (ja) * | 1997-12-09 | 2009-12-16 | 中外製薬株式会社 | ビタミンd3誘導体を含有するローション剤 |
BR122012030846B8 (pt) * | 1999-04-23 | 2021-05-25 | Leo Pharma As | composição farmacêutica não aquosa para uso dermatológico compreendendo calcipotriol e pelo menos um corticoesteróide, e, uso da mesma |
RU2271810C2 (ru) * | 2000-10-27 | 2006-03-20 | Лео Фарма А/С | Композиции местного применения, содержащие, по меньшей мере, один витамин d или один аналог витамина d и, по меньшей мере, один кортикостероид |
KR20050085787A (ko) * | 2002-12-17 | 2005-08-29 | 갈데르마 소시에떼아노님 | 칼시트리올 및 클로베타솔 프로피오네이트의 배합물을함유하는 약학 조성물 |
FR2848454B1 (fr) * | 2002-12-17 | 2007-03-30 | Galderma Res & Dev | Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide |
FR2867682B1 (fr) * | 2004-03-22 | 2009-06-05 | Galderma Res & Dev | Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise. |
FR2871694B1 (fr) * | 2004-06-17 | 2008-07-04 | Galderma Sa | Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises |
CN101247787B (zh) * | 2005-06-10 | 2011-10-05 | 盖尔德玛公司 | 以包含药物、成膜聚硅氧烷和至少一种挥发性溶剂为基础的经皮药物的控制释放 |
-
2006
- 2006-11-30 FR FR0655205A patent/FR2909284B1/fr not_active Expired - Fee Related
-
2007
- 2007-11-30 CN CN2007800438813A patent/CN101541304B/zh not_active Expired - Fee Related
- 2007-11-30 RU RU2009124913/15A patent/RU2448713C2/ru not_active IP Right Cessation
- 2007-11-30 KR KR1020097010879A patent/KR20090084898A/ko not_active Application Discontinuation
- 2007-11-30 CA CA002670601A patent/CA2670601A1/fr not_active Abandoned
- 2007-11-30 BR BRPI0717695A patent/BRPI0717695A2/pt not_active IP Right Cessation
- 2007-11-30 AU AU2007327368A patent/AU2007327368B2/en not_active Ceased
- 2007-11-30 WO PCT/FR2007/052432 patent/WO2008065316A2/fr active Application Filing
- 2007-11-30 AR ARP070105356A patent/AR064077A1/es not_active Application Discontinuation
- 2007-11-30 MX MX2009005307A patent/MX2009005307A/es active IP Right Grant
- 2007-11-30 JP JP2009538759A patent/JP2011504870A/ja active Pending
- 2007-11-30 EP EP07866552A patent/EP2101726A2/fr not_active Withdrawn
-
2009
- 2009-05-29 US US12/457,029 patent/US8741878B2/en not_active Expired - Fee Related
-
2012
- 2012-09-14 US US13/619,313 patent/US8741879B2/en not_active Expired - Fee Related
-
2014
- 2014-05-01 US US14/267,452 patent/US20140243297A1/en not_active Abandoned
- 2014-05-16 US US14/280,099 patent/US20140256689A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20130012484A1 (en) | 2013-01-10 |
FR2909284A1 (fr) | 2008-06-06 |
CN101541304B (zh) | 2013-05-01 |
CN101541304A (zh) | 2009-09-23 |
AU2007327368B2 (en) | 2013-08-15 |
RU2009124913A (ru) | 2011-01-10 |
RU2448713C2 (ru) | 2012-04-27 |
AU2007327368A1 (en) | 2008-06-05 |
MX2009005307A (es) | 2009-05-28 |
US20090298801A1 (en) | 2009-12-03 |
EP2101726A2 (fr) | 2009-09-23 |
US20140243297A1 (en) | 2014-08-28 |
BRPI0717695A2 (pt) | 2015-10-27 |
KR20090084898A (ko) | 2009-08-05 |
WO2008065316A3 (fr) | 2008-11-06 |
US8741879B2 (en) | 2014-06-03 |
WO2008065316A2 (fr) | 2008-06-05 |
CA2670601A1 (fr) | 2008-06-05 |
FR2909284B1 (fr) | 2012-09-21 |
US8741878B2 (en) | 2014-06-03 |
JP2011504870A (ja) | 2011-02-17 |
US20140256689A1 (en) | 2014-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR064077A1 (es) | Composiciones bajo forma de unguento sin vaselina que comprende un derivado de vitamina d y eventualmente un anti-inflamatorio esteroide | |
AR048878A1 (es) | Composiciones topicas de metadona y metodos para usarlas | |
AR059843A1 (es) | Nuevas composiciones topicas en forma de emulsion ac/ag que comprenden un glicol propenetrante | |
ECSP088889A (es) | Forma nueva de administración de racecadotril | |
AR059844A1 (es) | Nuevas composiciones topicas en forma de emulsion ac/ag que comprenden un glicol propenetrante | |
UY29701A1 (es) | Formulaciones líquidas para la administración controlada de derivados de bencisoxazol | |
CL2009000882A1 (es) | Un compuesto n-(4-cloro-3-(piridin-2-il)fenil)-4-(2-hidroxi-2-metilpropilsulfonil)-2-metilbenzamida, inhibidor de la via de señalización hedgehog; composición farmacéutica que comprende a dicho compuesto; y su uso para tratar el cancer. | |
EP2513343A4 (en) | METHODS AND COMPOSITIONS FOR TREATING SKIN INFLAMMATION | |
CL2008000510A1 (es) | Compuestos conjugados farmaco-ligandos, que se unen a citotoxinas potentes; composicion farmaceutica; y uso para retardar o detener el crecimiento de un tumor en un mamifero. | |
ES2478264T3 (es) | Glicerosomas y uso de estos en preparaciones farmacéuticas y cosméticas para aplicación tópica | |
CO6700827A2 (es) | Corticosteroides para el tratamiento de dolor de articulaciones | |
MX2010005210A (es) | Formulacion de aceite de oliva para alivio del dolor. | |
UY31456A1 (es) | Derivados de 2-pirazinona como inhibidores de la elastasa de los neutrofilos | |
CL2008003057A1 (es) | Combinacion farmaceutica que comprende un derivado de purina y un corticoide, agonista de beta-2 adrenoceptor, agente antimuscarinico, entre otros; composicion farmaceutica; y su uso para tratar enfermedades inflamatorias u obstructivas de las vias respiratorias. | |
CL2011000604A1 (es) | Compuestos derivados de multiheteroarilo, inhibidores de h-pgds, composicion farmaceutica que los comprende; utiles en el tratamiento de enfermedades inflamatorias y alergicas. | |
ECSP11010762A (es) | Composición tópica para el tratamiento de queratosis actínica | |
CL2011003327A1 (es) | Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales. | |
AR068669A1 (es) | Metodo para aliviar la queratoconjuntivitis seca | |
BR112014016550A8 (pt) | formulação de liberação retardada para reduzir a frequência de urinação e método de uso da mesma | |
CL2012001019A1 (es) | Composicion farmaceutica que comprende una proenzima de proteasa seleccionada de al menos tripsinogeno y quimiotripsinogeno y un agente activo seleccionado de al menos un compuesto de selenio, un compuesto vanilloide, un agente reductor de glicolisis citoplasmica y opcionalmente una glucosidohidrolasa; y uso para tratar cancer. | |
GT200600123A (es) | Derivados de tetrahidronaftalina, procedimientos para su preparacion y su uso como inhibidor de la inflamacion | |
BR112014016661A8 (pt) | formulação de liberação prolongada para reduzir a frequência de urinação e método de uso da mesma | |
PE20150773A1 (es) | Composiciones farmaceuticas para la liberacion sostenida de fenilefrina | |
BR112012022243A8 (pt) | Uso de um inibidor de autofagia baseado em tioxantona e de um composto indutor de autofagia para terapia de câncer, composição farmacêutica e kit farmacêutico | |
CL2011000722A1 (es) | Composicion farmaceutica en forma de unguento estable al almacenamiento, que comprende: a) un compuesto de vitamina d, b) un corticosteroide y c) un compuesto alquilamino sustituido, en un vehiculo de petrolato que opcionalmente contiene aceite mineral, tocoferol o una combinacion de ellos; uso en tratamiento de la psoriasis. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |